These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8355216)

  • 21. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    Ferry RC; Unsworth CD; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ; Peroutka SJ
    J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT2 receptors, roles and regulation.
    Leysen JE; Pauwels PJ
    Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1993 May; 43(5):755-61. PubMed ID: 8388989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
    Lai FM; Tanikella T; Cervoni P
    J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
    Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence that the guinea pig tracheal contractile serotonergic receptor is a 5-hydroxytryptamine2 receptor: use of 5-methyltryptamine and dipropyl-5-carboxamidotryptamine.
    Watts SW; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):271-5. PubMed ID: 8423530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain.
    McKenna DJ; Nazarali AJ; Himeno A; Saavedra JM
    Neuropsychopharmacology; 1989 Mar; 2(1):81-7. PubMed ID: 2803482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
    Rittenhouse PA; Bakkum EA; Van de Kar LD
    J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
    Rinaldi-Carmona M; Bouaboula M; Congy C; Oury-Donat F; Simiand J; Shire D; Casellas P; Soubrié P; Brelière JC; Le Fur G
    Eur J Pharmacol; 1993 Jun; 246(1):73-80. PubMed ID: 8354344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
    Pomfret DW; Schenck KW; Fludzinski P; Cohen ML
    J Pharmacol Exp Ther; 1987 May; 241(2):465-71. PubMed ID: 3572806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of 5-hydroxytryptamine receptors on isolated ovine uterine artery in late pregnancy.
    Zhang L; Dyer DC
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1236-44. PubMed ID: 2359025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation.
    Chaouloff F; Baudrie V; Coupry I
    Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors.
    Buckholtz NS; Zhou DF; Freedman DX
    Life Sci; 1988; 42(24):2439-45. PubMed ID: 3374263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serotonergic mechanisms of hippocampal kindled seizures in cats--effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and ketanserin].
    Nakamura M; Wada Y; Hasegawa H; Yamaguchi N
    No To Shinkei; 1993 Oct; 45(10):935-9. PubMed ID: 8268033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.